Melanocortin Receptor Agonist

Melanotan I

FDA-approved product existsSkin & hair
6.2/10

BioHarmony verdict

Worth trying

Melanotan I is most defensible for photoprotection in EPP and planned UV exposure, with Langendonk 2015 reporting 69.4 vs 40.8 hours of pain-free sun exposure in the US trial. The wellness case is narrower than the prescription afamelanotide evidence.

Read full report

What is Melanotan I?

Melanotan I (Afamelanotide) is a synthetic MC1R-selective alpha-MSH analog with prescription-grade evidence for erythropoietic protoporphyria, where Langendonk reported 69.4 versus 40.8 hours of pain-free sun exposure in the US Phase III arm. Afamelanotide works by increasing eumelanin through MC1R, which explains why the upside is strongest for photoprotection and pigment-related use cases. Melanotan I earns a worth-trying score because regulated SCENESSE has meaningful human evidence and the intrinsic afamelanotide safety profile is manageable with dermatology monitoring.

From the BioHarmony report, reviewed 2026-09-08.

How it is thought to work

MC1R activation increases eumelanin and UV tolerance

Safety watch-outs

  • New or rapidly changing mole, oral pigmentation, or bleeding lesion
  • Severe headache, confusion, vision change, chest pain, or neurologic symptoms
  • Priapism, severe abdominal pain, dark urine, or muscle pain after dosing

Full risk profile in the BioHarmony report.

Dosing as published

No approved-label or study protocol is recorded for Melanotan I yet.

More reported protocols

Members

Members can compare additional reported doses, schedules, and preparation notes.

Educator coverage (2)

Attributed viewpoints, separate from primary research.

Trust & sourcing

US approvalFDA-approved product exists
CompoundingAfamelanotide has an approved implant product; other products represented as Melanotan I are not thereby FDA approved
Last checked2026-07-13
Next review2026-10-11 (overdue, details paused)

Primary sources

Sources are still being reviewed for this compound.

Free guide

The Ultimate Peptides Guide

Spot stronger candidates, weak evidence, and seller red flags before you buy.

Free. Includes evidence and regulatory updates. Unsubscribe anytime.